6-Shogaol suppresses the growth of breast cancer cells by inducing apoptosis and suppressing autophagy via targeting notch signaling pathway.
Antineoplastic Agents, Phytogenic
/ pharmacology
Apoptosis
/ drug effects
Autophagy
/ drug effects
Breast Neoplasms
/ drug therapy
Catechols
/ pharmacology
Cell Proliferation
/ drug effects
Cisplatin
/ pharmacology
Cyclin D1
/ genetics
Dose-Response Relationship, Drug
Female
G2 Phase Cell Cycle Checkpoints
/ drug effects
Humans
MCF-7 Cells
Oxaliplatin
/ pharmacology
Receptors, Notch
/ genetics
Signal Transduction
Transcription Factor HES-1
/ genetics
6-shogaol
Apoptosis
Autophagy
Cell cycle analysis
Real-time PCR (qPCR)
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
01
04
2020
revised:
03
05
2020
accepted:
20
05
2020
pubmed:
9
6
2020
medline:
2
3
2021
entrez:
8
6
2020
Statut:
ppublish
Résumé
Breast cancer is one of the most commonly diagnosed cancer among women globally. Shogaol, the active constituent of many spices belonging to the Zingiberaceae family, has received wide attention among other shogaols in terms of its anticancer activity against different neoplasms. To date, its efficacy at the detailed molecular level against breast cancer has not been established. In the current study, we investigated the cytotoxic potential and the underlying molecular details of 6-shogaol against breast adenocarcinomacells (MCF-7), and breast ductal carcinoma cells (T47D). Cytotoxicity assay, cell cycle analysis. Real-time PCR (qPCR), apoptosis and autophagy techniques were used for the determination and molecular investigation of its anticancer properties. The current study shows that, Notch signaling downregulation (Hes1 and CyclinD1 genes), caused by 6-shogaol, lead to antiproliferative activity in breast cancer cells. The study further shows that treatment with 6-shogaol induced significant and time dependent cell cycle accumulation in G 6-Shogaol is a promising candidate to be considered as a treatment of breast cancer.
Identifiants
pubmed: 32505819
pii: S0753-3322(20)30494-7
doi: 10.1016/j.biopha.2020.110302
pii:
doi:
Substances chimiques
Antineoplastic Agents, Phytogenic
0
CCND1 protein, human
0
Catechols
0
Receptors, Notch
0
Transcription Factor HES-1
0
Oxaliplatin
04ZR38536J
Cyclin D1
136601-57-5
HES1 protein, human
149348-15-2
shogaol
83DNB5FIRF
Cisplatin
Q20Q21Q62J
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110302Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Authors declare that there is no competing conflict of interest.